Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Leap Therapeutics Inc (NASDAQ: LPTX) closed the day trading at $0.42 down -6.31% from the previous closing price of $0.45. In other words, the price has decreased by -$6.31 from its previous closing price. On the day, 0.94 million shares were traded. LPTX stock price reached its highest trading level at $0.4638 during the session, while it also had its lowest trading level at $0.411.
Ratios:
For a better understanding of LPTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.34 and its Current Ratio is at 1.34. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on January 29, 2025, Downgraded its rating to Neutral and sets its target price to $1.25 from $9 previously.
On June 28, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $8.Rodman & Renshaw initiated its Buy rating on June 28, 2024, with a $8 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LPTX now has a Market Capitalization of 23737120 and an Enterprise Value of -727837.
Stock Price History:
The Beta on a monthly basis for LPTX is -0.07, which has changed by -0.8740845 over the last 52 weeks, in comparison to a change of 0.18286073 over the same period for the S&P500. Over the past 52 weeks, LPTX has reached a high of $3.96, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -2.58%, while the 200-Day Moving Average is calculated to be -7.28%.
Shares Statistics:
Over the past 3-months, LPTX traded about 3.55M shares per day on average, while over the past 10 days, LPTX traded about 1862700 shares per day. A total of 41.44M shares are outstanding, with a floating share count of 40.92M. Insiders hold about 27.77% of the company’s shares, while institutions hold 14.75% stake in the company. Shares short for LPTX as of 1760486400 were 2499781 with a Short Ratio of 0.70, compared to 1757894400 on 1417952. Therefore, it implies a Short% of Shares Outstanding of 2499781 and a Short% of Float of 4.95.
Earnings Estimates
Leap Therapeutics Inc (LPTX) is presently subject to a detailed evaluation by 1.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$1.11 and -$1.11 for the fiscal current year, implying an average EPS of -$1.11. EPS for the following year is -$0.53, with 1.0 analysts recommending between -$0.53 and -$0.53.
